Efficacy and Safety of an Oral Growth Hormone Drug in the Treatment of Fibromyalgia

This study has been completed.
Sponsor:
Collaborator:
Merck Sharp & Dohme Corp.
Information provided by (Responsible Party):
Robert Bennett MD, Bennett, Robert, M.D.
ClinicalTrials.gov Identifier:
NCT00116129
First received: June 27, 2005
Last updated: August 2, 2012
Last verified: August 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: April 2008
  Primary Completion Date: January 2008 (Final data collection date for primary outcome measure)